Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Diabetes (2001) 50:158897
It is licensed only for type 2 diabetes management and cardiovascular risk reduction in patients with established cardiovascular disease
A: The usage instructions recommend taking the tablet as directed by a health professional
Patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use tirzepatide
US$ 21.62
US$ 22.47
US$ 28.51
US$ 23.83
US$ 21.00
US$ 20.92
US$ 29.35
US$ 20.02
US$ 24.89
